March 24, 2023
aXichem AB (publ)’s rights issue was subscribed to 70 percent
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN Read the article here
Nature Inspired
Human Made
Human Made
aXichem is an innovative biotechnology company specialising in development of natural analogue ingredients.
View our webinar!
We are holding webinars about aXivite for research and development professionals in the dietary supplement industry. If you are interested in watching a streamed version of our latest webinar, please click here to get access.
News
March 24, 2023
aXichem AB (publ):s företrädesemission tecknades till 70 procent
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, HELT ELLER DELVIS, DIREKT Read the article here
March 22, 2023
Today is the final day for subsciribing to shares in aXichem’s rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN Read the article here
March 22, 2023
Idag är sista teckningsdag i aXichems företrädesemission
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, HELT ELLER DELVIS, DIREKT Read the article here
March 20, 2023
aXichem has submitted answers to questions received from EFSA regarding the company’s Feed Additive application
aXichem AB (publ), that develops and markets natural analogue industrial Read the article here
About aXichem
Nature Inspired: We draw from the genius of nature and respect nature in return. Learn about the philosophy behind aXichem brand.
Science and R&D
Human made:
Our curiosity and passion for knowledge leads us to developing innovative solutions which result in environmental and human benefits.
Our curiosity and passion for knowledge leads us to developing innovative solutions which result in environmental and human benefits.
For Investors
aXichem is listed on Nasdaq First North Growth Market. Our aim is to provide relevant and transparent information to analysts, investors and media, with the latest news and events.
AXICHEM A
(AXIC A)
6.9
SEK
-0.24 / -3.36%
High
7.12
Low
6.56
Volume
38978
Turnover
269855.46
March 24, 2023 17:29:56